Current Cancer Drug Targets, Volume 11 - Number 8

The Phosphoinositide 3-Kinase Signaling Pathway as a Therapeutic Target in Grade IV Brain Tumors

, 11(8): 894 - 918

K. Holand, F. Salm and A. Arcaro

DOI: 10.2174/156800911797264743

Pharmacological Characterization of Histone Deacetylase Inhibitor and Tumor Cell-Growth Inhibition Properties of New Benzofuranone Compounds

, 11(8): 919 - 928

C. Blanquart, M. Francois, C. Charrier, P. Bertrand and M. Gregoire

DOI: 10.2174/156800911797264761

L-Asparaginase and Inhibitors of Glutamine Synthetase Disclose Glutamine Addiction of β-Catenin-Mutated Human Hepatocellular Carcinoma Cells

, 11(8): 929 - 943

DOI: 10.2174/156800911797264725

Comparing the Efficacy of Sunitinib with Sorafenib in Xenograft Models of Human Hepatocellular Carcinoma: Mechanistic Explanation

, 11(8): 944 - 953

H. Huynh, S. P. Choo, H. C. Toh, W. M. Tai, A. Y.F. Chung, P. K.H. Chow, R. Ong and K. C. Soo

DOI: 10.2174/156800911797264716

Active-Targeted Nanotherapy Strategies for Prostate Cancer

, 11(8): 954 - 965

M. Katsogiannou, L. Peng, C. V. Catapano and P. Rocchi

DOI: 10.2174/156800911797264770

H+-myo-Inositol Transporter SLC2A13 as a Potential Marker for Cancer Stem Cells in an Oral Squamous Cell Carcinoma

, 11(8): 966 - 975

D. G. Lee, J.-H. Lee, B. K. Choi, M.-J. Kim, S.-M. Kim, K. S. Kim, K. Chang, S. H. Park, Y.-S. Bae and B. S. Kwon

DOI: 10.2174/156800911797264752

RNAi Screening Identifies TAK1 as a Potential Target for the Enhanced Efficacy of Topoisomerase Inhibitors

, 11(8): 976 - 986

S. E. Martin, Z.-H. Wu, K. Gehlhaus, T. L. Jones, Y.-W. Zhang, R. Guha, S. Miyamoto, Y. Pommier and N. J. Caplen

DOI: 10.2174/156800911797264734

Reactivation of p53 by Inhibiting Mdm2 E3 Ligase: A Novel Antitumor Approach

, 11(8): 987 - 994

J. Di, Y. Zhang and J. Zheng

DOI: 10.2174/156800911797264789

Webmaster Contact:
Copyright © 2018 Bentham Science